Michael Rosove, MD, UCLA Health

Dr. Michael Harry Rosove is a Hematology / Oncology Specialist. He graduated with honors from UCLA School Of Medicine in 1973. Having more than 44 years of diverse experiences, especially in hematology/oncology. Dr. Rosove is affiliated with many hospitals including Ronald Reagan UCLA Medical Center, Santa Monica - UCLA Medical Center & Orthopaedic Hospital, and cooperates with other doctors and specialists in medical group UC Regents.

Christy Russell, MD, USC Norris Comprehensive Cancer Center and Hospital

Christy Russell, MD, is associate professor of medicine at the Keck School of Medicine of USC, Director of the USC Norris Breast Center and chief of medicine at USC Norris Cancer Hospital. She is a medical oncologist specializing in breast cancer at the USC Norris Comprehensive Cancer Center and. As a board certified physician in both internal medicine and medical oncology, Russell has served as chief of staff and as a member of the Norris Leadership Council. Russell lectures nationally and internationally and has authored numerous publications on breast and testicular cancer. She is a member of the Medical Advisory Board for the Wellness Community in Pasadena and a board member of the American Cancer Society.

George Somlo, MD, City of Hope

George Somlo, MD, F.A.C.P., is an internationally known breast cancer and hematology researcher at City of Hope, and director of pharmaceutical initiatives at the institution. Dr. Somlo is currently professor with joint appointments in the Departments of Medical Oncology & Therapeutics Research and Hematology & Hematopoietic Cell Transplantation. Among his many institutional functions, he is president of the medical staff and a member of the City of Hope board of directors. Dr. Somlo served as director of breast oncology, co-director of the Breast Cancer Program and director of the Multiple Myeloma Program. Dr. Somlo is particularly interested in collaborations focusing on triple negative breast cancer and overcoming breast cancer stem cell resistance in the preclinical and subsequently clinical settings.

Patrick Soon-Shiong, MD, Chan Soon-Shiong Institute for Medicine

Patrick Soon-Shiong, MD, is a physician, surgeon, researcher, philanthropist and scientist who invented and developed the revolutionary drug Abraxane, which has received FDA approval for the treatment of metastatic breast cancer, lung cancer and advanced pancreatic cancer. Abraxane is considered the standard-of-care and first line therapy across a spectrum of cancer types in both the United States and Europe. Over the course of Dr. SoonShiong’s career, he has pioneered novel therapies for both diabetes and cancer, published over 100 scientific papers, and has been granted over 230 patents worldwide for groundbreaking advancements spanning myriad fields of technology and medicine.

Prev